Showing results (41-50 of 50) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Journal of Affective Disorders|July 12, 2005
Patient-based utilities for bipolar disorder-related health statesDennis A Revicki, Jennifer Hanlon, Silas Martin, et al.Journal of Market Access & Health Policy|November 7, 2019
The impact of non-medical switching among ambulatory patients: an updated systematic literature reviewErin R Weeda, Elaine Nguyen, Silas Martin, et al.Anatomy and Embryology|June 13, 2003
Lectin histochemistry of the lymphoid organs of the chickenJulia Jörns, Ulrich Mangold, Ulrich Neumann, et al.Current Medical Research and Opinion|May 12, 2018
CMS hospital readmission reduction program and anticoagulants received following a total hip and knee arthroplasty dischargeFrançois Laliberté, Craig I Coleman, Brahim Bookhart, et al.Journal of Medical Economics|October 29, 2014
Economic simulation of canagliflozin and sitagliptin treatment outcomes in patients with type 2 diabetes mellitus with inadequate glycemic controlMarie-Hélène Lafeuille, Amanda Melina Grittner, Jonathan Gravel, et al.The American Journal of Managed Care|February 12, 2014
Quality measure attainment in patients with type 2 diabetes mellitusMarie-Hélène Lafeuille, Amanda M Grittner, Jonathan Gravel, et al.Current Medical Research and Opinion|November 23, 2017
Implications of stroke and bleeding risk scores and comorbidities on episode-based bundled payments for patients with nonvalvular atrial fibrillationScott Kaatz, Craig I Coleman, Brahim Bookhart, et al.Glycobiology|July 30, 2002
Preferential binding of the anticancer drug rViscumin (recombinant mistletoe lectin) to terminally alpha2-6-sialylated neolacto-series gangliosidesJohannes Müthing, Monika Burg, Babette Möckel, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 3, 2004
Tumor-associated CD75s gangliosides and CD75s-bearing glycoproteins with Neu5Acalpha2-6Galbeta1-4GlcNAc-residues are receptors for the anticancer drug rViscuminJohannes Müthing, Iris Meisen, Bernhard Kniep, et al.Current Medical Research and Opinion|September 23, 2015
Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measureColleen A McHorney, Concetta Crivera, François Laliberté, et al.Pageof 5